Mondaycom Ltd vs Vaxcyte Inc. Common Stock — how do they compare? Mondaycom Ltd trades at $87.2 (market cap $3.57B), while Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B). The key difference: Vaxcyte Inc. Common Stock is far larger — about 2.9× Mondaycom Ltd's market cap, and Vaxcyte Inc. Common Stock is trading nearer its 52-week high, Mondaycom Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Mondaycom Ltd for 16 Days and Vaxcyte Inc. Common Stock for 0 Days on average.
| MNDY | PCVX | |
|---|---|---|
Market Cap | $3.57B | $10.51B |
Volume | 1,023,013 | 2,644,694 |
Sector | Technology | Health |
52-Week High | $205.24 | $73.82 |
52-Week Low | $58.81 | $40.32 |
Typical Hold Time | 16 Days | 0 Days |
Enterprise Value | $2.74B | $9.14B |
Signals from Pluang's Aura AI — not financial advice
Monday.com (MNDY) trades at $84.69, showing minimal daily movement (-0.08%) with neutral technical signals. The company demonstrates strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust revenue growth from $1.23B to $1.4B. Recent news highlights AI integration at Elevate '26 conference and inclusion in multiple growth stock lists, while technical indicators show mixed signals with RSI at neutral levels and key support at $83.
The stock presents a compelling growth story with 61.5% analyst buy ratings and a $108.64 consensus target offering 28% upside. However, elevated valuation multiples (P/E 35.83, EV/EBITDA 50.12) and competitive pressures from Meta's enterprise software push pose risks. Net cash flow turned negative in 2026 (-$737M) despite strong operating performance, requiring monitoring of capital allocation.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Monday.com Ltd. is a cloud-based software company providing a Work OS (Operating System) that enables organizations to manage projects, processes, and daily work. The platform is highly customizable, enabling teams to build tailored applications and workflows for a range of use cases, from marketing and sales to software development and HR. monday.com serves clients across numerous industries, aiming to improve transparency, collaboration, and efficiency across the entire enterprise.
Read more on MNDY →Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →